Document is current
Any future updates will be listed below
-
Authors
Suzuki, Koji https://orcid.org/0000-0003-1358-7069
Akiyama, Mitsuhiro https://orcid.org/0000-0001-5075-8977
Shimanuki, Kanako https://orcid.org/0009-0006-0001-1078
Kaneko, Yuko https://orcid.org/0000-0003-2646-5765
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 26 March 2025
First Online: 7 April 2025
Declarations
:
: M.A. has received speaking fees from AbbVie, Asahi-Kasei, Astellas, Boehringer Ingelheim, Chugai, Eisai, Eli Lilly, Janssen, Novartis, Pfizer, Taisho, UCB, Gilead Sciences. Y. K. has received research grants from AbbVie, Eisai, Sanofi, Chugai, Mitsubishi-Tanabe, Taisho, and has received scholarship grant from Asahi-Kasei, Eisai, Boehringer Ingelheim, Taisho, and has received speaking fees from AbbVie, Asahi-Kasei, Astellas, Ayumi Pharmaceutical Corporation, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Eisai, Eli Lilly, Glaxo Smith Kline, Janssen, Novartis, Pfizer, UCB, Gilead Sciences. K.S. declare no conflict of interest.
